On air · 1 of 3 networks
Allogene Therapeutics
- allogene.com
- Healthcare & Life Sciences
- US
- 236 employees
Allogene Therapeutics’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 112. Watch Allogene Therapeutics with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 108 | Checked 30 Oct 2026 | See all 112 ads → | ||
| Meta | Not checked | — | |||
| Not checked | — |
Allogene Therapeutics has 108 live LinkedIn ads.
Latest ads
- LINKEDIN · JOBSince 5 Jan 2026
- LINKEDIN · IMAGERecorded 4 Sept 2026
What if preventing relapse in LBCL was within reach? The ALPHA3 clinical trial is exploring an investigational add-on to 1L therapy that could help protect your patients from the impact of relapse. Discover more about this innovative approach.
- LINKEDIN · IMAGERecorded 4 Sept 2026
30% of LBCL patients may relapse after 1L therapy. The ALPHA3 clinical trial offers a potential alternative to the watch & wait approach. Find out more about the ALPHA3 clinical trial.
- LINKEDIN · IMAGERecorded 4 Sept 2026
A new consolidation approach is being studied to help predict and potentially prevent relapse in DLBCL patients receiving first-line therapy. Explore the possibilities with the ALPHA3 clinical trial.
- LINKEDIN · IMAGERecorded 4 Sept 2026
Imagine helping your LBCL patients avoid the devastation of relapse. The ALPHA3 clinical trial is evaluating a novel add-on to 1L therapy – designed to predict and potentially prevent relapse. Explore the possibilities.
- LINKEDIN · IMAGERecorded 4 Sept 2026
Predicting relapse in LBCL patients undergoing 1L therapy could revolutionize patient care. Explore the possibilities with the ALPHA3 clinical trial.
6 of 112 adsSign up to see every Allogene Therapeutics ad, filter by format and date, and get alerts on new ones.
See all 112 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.